209 related articles for article (PubMed ID: 27796754)
1. Ketamine Self-Administration Reduces the Homeostasis of the Glutamate Synapse in the Rat Brain.
Caffino L; Piva A; Giannotti G; Di Chio M; Mottarlini F; Venniro M; Yew DT; Chiamulera C; Fumagalli F
Mol Neurobiol; 2017 Nov; 54(9):7186-7193. PubMed ID: 27796754
[TBL] [Abstract][Full Text] [Related]
2. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.
Lorrain DS; Baccei CS; Bristow LJ; Anderson JJ; Varney MA
Neuroscience; 2003; 117(3):697-706. PubMed ID: 12617973
[TBL] [Abstract][Full Text] [Related]
3. Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment.
Ren Z; Pribiag H; Jefferson SJ; Shorey M; Fuchs T; Stellwagen D; Luscher B
Biol Psychiatry; 2016 Sep; 80(6):457-468. PubMed ID: 27062563
[TBL] [Abstract][Full Text] [Related]
4. Modulation by chronic stress and ketamine of ionotropic AMPA/NMDA and metabotropic glutamate receptors in the rat hippocampus.
Elhussiny MEA; Carini G; Mingardi J; Tornese P; Sala N; Bono F; Fiorentini C; La Via L; Popoli M; Musazzi L; Barbon A
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110033. PubMed ID: 32640261
[TBL] [Abstract][Full Text] [Related]
5. Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.
de Bartolomeis A; Sarappa C; Buonaguro EF; Marmo F; Eramo A; Tomasetti C; Iasevoli F
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():1-12. PubMed ID: 23800465
[TBL] [Abstract][Full Text] [Related]
6. Bidirectional variation in glutamate efflux in the medial prefrontal cortex induced by selective positive and negative allosteric mGluR5 modulators.
Isherwood SN; Robbins TW; Dalley JW; Pekcec A
J Neurochem; 2018 Apr; 145(2):111-124. PubMed ID: 29315577
[TBL] [Abstract][Full Text] [Related]
7. Metaplastic Effects of Ketamine and MK-801 on Glutamate Receptors Expression in Rat Medial Prefrontal Cortex and Hippocampus.
Piva A; Caffino L; Mottarlini F; Pintori N; Castillo Díaz F; Fumagalli F; Chiamulera C
Mol Neurobiol; 2021 Jul; 58(7):3443-3456. PubMed ID: 33723767
[TBL] [Abstract][Full Text] [Related]
8. Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons.
El Iskandrani KS; Oosterhof CA; El Mansari M; Blier P
J Psychopharmacol; 2015 Jul; 29(7):792-801. PubMed ID: 25759403
[TBL] [Abstract][Full Text] [Related]
9. mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties.
Swedberg MD; Ellgren M; Raboisson P
J Pharmacol Exp Ther; 2014 Apr; 349(1):155-64. PubMed ID: 24472725
[TBL] [Abstract][Full Text] [Related]
10. Ketamine Self-Administration Elevates αCaMKII Autophosphorylation in Mood and Reward-Related Brain Regions in Rats.
Caffino L; Piva A; Mottarlini F; Di Chio M; Giannotti G; Chiamulera C; Fumagalli F
Mol Neurobiol; 2018 Jul; 55(7):5453-5461. PubMed ID: 28948570
[TBL] [Abstract][Full Text] [Related]
11. Multiprobe molecular imaging of an NMDA receptor hypofunction rat model for glutamatergic dysfunction.
Kosten L; Verhaeghe J; Verkerk R; Thomae D; De Picker L; Wyffels L; Van Eetveldt A; Dedeurwaerdere S; Stroobants S; Staelens S
Psychiatry Res Neuroimaging; 2016 Feb; 248():1-11. PubMed ID: 26803479
[TBL] [Abstract][Full Text] [Related]
12. Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in a ketamine-based animal model of schizophrenia.
Zurawek D; Salerno-Kochan A; Dziedzicka-Wasylewska M; Nikiforuk A; Kos T; Popik P
Schizophr Res; 2018 Feb; 192():423-430. PubMed ID: 28433499
[TBL] [Abstract][Full Text] [Related]
13. Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies.
Pham TH; Gardier AM
Pharmacol Ther; 2019 Jul; 199():58-90. PubMed ID: 30851296
[TBL] [Abstract][Full Text] [Related]
14. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
15. Long-term NMDA receptor inhibition affects NMDA receptor expression and alters glutamatergic activity in developing rat hippocampal neurons.
Sinner B; Friedrich O; Lindner R; Bundscherer A; Graf BM
Toxicology; 2015 Jul; 333():147-155. PubMed ID: 25937004
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection.
Radenovic L; Selakovic V
Brain Res Bull; 2005 Sep; 67(1-2):133-41. PubMed ID: 16140172
[TBL] [Abstract][Full Text] [Related]
17. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
[TBL] [Abstract][Full Text] [Related]
18. Morphine induction of c-fos expression in the rat forebrain through glutamatergic mechanisms: role of non-n-methyl-D-aspartate receptors.
Garcia MM; Anderson AT; Edwards R; Harlan RE
Neuroscience; 2003; 119(3):787-94. PubMed ID: 12809699
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive
Witkin JM; Mitchell SN; Wafford KA; Carter G; Gilmour G; Li J; Eastwood BJ; Overshiner C; Li X; Rorick-Kehn L; Rasmussen K; Anderson WH; Nikolayev A; Tolstikov VV; Kuo MS; Catlow JT; Li R; Smith SC; Mitch CH; Ornstein PL; Swanson S; Monn JA
J Pharmacol Exp Ther; 2017 Apr; 361(1):68-86. PubMed ID: 28138040
[TBL] [Abstract][Full Text] [Related]
20. Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia.
Zavitsanou K; Nguyen V; Newell K; Ballantyne P; Huang XF
J Chem Neuroanat; 2008 Oct; 36(2):71-6. PubMed ID: 18640263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
